![Human Monoclonal Antibody "S309" Neutralizes SARS and COVID-19 Coronaviruses, Fast-Tracked Toward Possible Clinical Trials | Technology Networks Human Monoclonal Antibody "S309" Neutralizes SARS and COVID-19 Coronaviruses, Fast-Tracked Toward Possible Clinical Trials | Technology Networks](https://assets.technologynetworks.com/production/dynamic/images/content/335034/human-monoclonal-antibody-s309-neutralizes-sars-and-covid-19-coronaviruses-fast-tracked-toward-335034-960x540.jpg?cb=10720349)
Human Monoclonal Antibody "S309" Neutralizes SARS and COVID-19 Coronaviruses, Fast-Tracked Toward Possible Clinical Trials | Technology Networks
![Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains | Nature Communications Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-022-31615-7/MediaObjects/41467_2022_31615_Fig3_HTML.png)
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains | Nature Communications
![Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains | Nature Communications Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-022-31615-7/MediaObjects/41467_2022_31615_Fig4_HTML.png)